Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathwaysQi Deng(Tianjin First Center Hospital), YU-MING LI(Tianjin First Center Hospital)Experimental and Therapeutic MedicineFebruary 5, 201510.3892/etm.2015.2264Cited by 8SaveCiteExport RISWatch citationsRelated Papers<p>Low Level Donor Chimerism of CD19 CAR-T Cells Returned to Complete Donor Chimerism in Patients with Relapse After Allo-Hematopoietic Stem Cell Transplant</p>|OncoTargets and Therapy|2020|6